The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?
暂无分享,去创建一个
E. Burton | H. Kantarjian | G. Garcia-Manero | J. Cortes | A. Quintás-Cardama | S. Verstovsek | F. Ravandi | G. Borthakur | E. Jabbour | S. O'brien | J. Shan | A. Quintás-Cardama | Jenny Shan